Morgan Stanley Pet Vivo Holdings, Inc. Transaction History

Morgan Stanley

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$1.25 - $3.97 $168 - $535	-135 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.4 - $5.01 $324 - $676	135 New	135 $1,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $4.83M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.